Jason is an accomplished start-up founder and executive with experience developing disruptive solutions to address healthcare’s most urgent challenges. He is a co-founder of Endpoint Health, an AI-powered precision immunology company, where he is currently a board member and CEO. Prior to Endpoint health he
co-founded and served as a board member of GeneWEAVE, a diagnostics company that developed rapid tests to detect and guide therapy choice for serious infections. Started in 2010, GeneWEAVE raised $25M in venture financing and was acquired by Roche in 2015. He is an angel investor focused on pre-seed/seed stage healthcare companies with data, diagnostic, and therapeutic indications. Jason received an MBA from Cornell University and lives in San Jose, CA with his wife and two daughters.